BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.

Abstract

SARS-CoV-2 vaccination is the standard of care for the prevention of COVID-19 disease. Although vaccination triggers both humoral and cellular immune response, COVID-19 vaccination efficacy is currently evaluated by measuring antibodies only, whereas adaptative cellular immunity is unexplored. Our aim is to test humoral and cell-mediated response after three doses of BNT162b vaccine in two cohorts of fragile patients: Common Variable Immunodeficiency (CVID) patients and Kidney Transplant Recipients (KTR) patients compared to healthy donors. We enrolled 10 healthy controls (HCs), 19 CVID patients and 17 KTR patients. HC BNT162b third dose had successfully mounted humoral immune response. A positive correlation between Anti-Spike Trimeric IgG concentration and neutralizing antibody titer was also observed. CVID and KTR groups showed a lower humoral immune response compared to HCs. IFN-γ release induced by epitopes of the Spike protein in stimulated CD4+ and CD8+ T cells was similar among vaccinated HC, CVID and KTR. Patients vaccinated and infected showed a more efficient humoral and cell-mediated response compared to only vaccinated patients. In conclusion, CVID and KTR patients had an efficient cell-mediated but not humoral response to SARS-CoV-2 vaccine, suggesting that the evaluation of T cell responses could be a more sensitive marker of immunization in these subjects.

• Authors: Evelina La Civita, Carla Zannella, Stefano Brusa, Paolo Romano, Elisa Schettino, Fabrizio Salemi, Rosa Carrano, Luca Gentile, Alessandra Punziano, Gianluca Lagnese, Giuseppe Spadaro, Gianluigi Franci, Massimiliano Galdiero, Daniela Terracciano, Giuseppe Portella, Stefania Loffredo
• Journal: Viruses (Viruses) Vol. 15 Issue 8 (07 30 2023) ISSN: 1999-4915 [Electronic] Switzerland
• PMID: 37632002 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• BNT162 Vaccine
• COVID-19 Vaccines
• Antibodies, Neutralizing

Topics

• Humans
• BNT162 Vaccine
• SARS-CoV-2
• COVID-19 Vaccines
• Common Variable Immunodeficiency
• COVID-19 (prevention & control)
• CD8-Positive T-Lymphocytes
• Kidney Transplantation
• Antibodies, Neutralizing